Merck gives Moderna $ 250 million for cancer mRNA vaccine
The drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
Read moreThe drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
Read moreIt is called Molnupiravir and for days we have been talking about nothing but this antiviral that can help us give a ...
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
© 2023 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.